ABLYNX, created in 2002 (Belgium), from 2757 sister brands and 17478 competing brands. ABLYNX is owned by SANOFI, listed on the stock exchange of Paris Its International Securities Identification Number (ISIN) is FR0000120578. ABLYNX is part of the Drug Manufacturers activity sector.
Investment simulator :
Portfolio valuation
SANOFI
(ABLYNX)
over 5 years*
EUR 108.23